Brain Canada Brain Canada
FR Donate

The Canadian Prospective Cohort Study to Understand Progression in Multiple Sclerosis (CanProCo)

Principal Investigator:
  • Jiwon Oh, St. Michael's Hospital
Team Members:
  • Scott Patten, University of Calgary
  • Larry Lynd, University of British Columbia
  • Shannon Kolind, University of British Columbia
  • Anthony Traboulsee, University of British Columbia
  • Alexandre Prat, CHUM Research Centre, University of Montréal
  • Roger Tam, University of British Columbia
  • Penelope Smyth, University of Alberta
  • MS Society of Canada
  • Biogen Canada
  • Roche Canada

Project Overview

Progression – or the steady worsening of disease and increase in disability – is a challenging reality faced by people affected by MS, and despite major advances in MS research, the mechanism of progression and the ways in which researchers and clinicians can track progression are still not fully understood. The CanProCo can have significant implications on how those living with MS manage and understand their illness from diagnoses and throughout the various stages of the disease. This study will look at progression from the biological, physical, and socioeconomic perspectives, and will meaningfully engage people living with MS so that their individual experiences are captured. Ultimately, the goal of the cohort is to connect biological findings with real world and clinical findings to create a comprehensive picture of progression in MS, with the hope that researchers will better understand the unpredictable nature of MS and find a cure.